Phio Pharmaceuticals Corp.
PHIO
$1.24
-$0.02-1.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.82% | -56.96% | -17.33% | 17.87% | 14.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 602.56% | 117.31% | 240.00% | 22.86% | -71.11% |
| Change in Net Operating Assets | -92.13% | 139.92% | -901.89% | 509.46% | 133.08% |
| Cash from Operations | -51.64% | -6.76% | -42.94% | 36.60% | 42.15% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 814.82% | -22.45% | -- | -- | -43.59% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 815.50% | -23.55% | -- | 229,425.00% | -43.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129,175.00% | -110.12% | -40.86% | 491.86% | -124.24% |